Hayat Ali Ahmed Fadul* and Dr. Ageeb Mohammed Hassan


Background: Renal cell carcinoma (RCC) is the most common adult renal epithelial cancer in the United States and the ninth most common malignancy in Europe in 2008 until recently. Renal cell carcinoma continues to be a difficult malignancy to treat because of its ability to spread asymptomatically and its inherent resistance to conventional chemotherapy. Objective: To evaluate immunohistochemical expression of vascular endothelial growth factor in renal cell carcinoma in our population and correlate its expression with different variables such as age and grade, also determination the specificity of vascular endothelial growth factor in renal cell carcinoma by using immune-histochemical technique. Materials and methods: this descriptive cross sectiona studyl for analyzing data from 40 formalin-fixed of paraffin-embedded tissues. These sections from all cases were subjected to stain with haematoxylin and eosin (H&E) for histopathological examination and immunohistochemical technique for VEGF. Results: The results show that 22 of 40 (55%) with grade 1 and 3 each one had 11(27.5%) frequencies and 12 (30%) frequencies with grade 2 while grade 4 had 6 (15%) frequencies, also we found that 32 (80%) diagnosed with clear cell renal cell carcinoma ccRCC, 2 (5%) chromophope, 5 (12.5%) papillary and 1(2.5%) was collecting duct, the expression of vascular endothelial growth factor marker in renal cell carcinoma were 29 (72.5%) out of 40 samples, the expression rate of ccRCC, papillary and chromophope were 24 (60%), 3 (7.5%) and 2 (5%) respectively for vascular endothelial growth factor marker with significant (.211), the expression rate of vascular endothelial growth factor marker in grade 1,2,3 and 4 were 3 (7.5%), 9 (22.5%), 11 (27.5%) and 6 (15%) respectively with significant (0.000). Conclusion: In this study we conclude that the expression of VEGF marker in grade 1 and 2 were 30% while in grade 3 and 4 was 70% so it’s had a higher microvessele density than those without or low expression. Also we show that the specifity of vascular endothelial growth factor marker were 72.5% and must be used in investigations as prognostic value.

Keywords: Vascular endothelial growth factor, Immunohistochemistry, Histopathology.

[Full Text Article]   [Download Certificate]


Forgot Password  |  Register


Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation


    MAY 2024 Issue has been successfully launched on 1 MAY 2024.

  • EJBPS New Impact Factor

    EJBPS Impact Factor has been Increased to 7.482 for Year 2024.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.


UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS


Copyright From

Covering Letter

                        Author Instruction